Conversely, depletion of C/EBPβ in similar transgenic mice with human α‐Syn resulted in reduced expression of α‐Syn, leading to mitigated PD pathologies and motor impairments (Wu et al., 2021). The gene discussed is CEBPB; the disease is Parkinson disease.